There were 1,411 press releases posted in the last 24 hours and 438,482 in the last 365 days.

TOMI™ Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2015 Results

- Increased net revenue 69% in Q4 2015 and 86% in full year 2015 from prior year periods -
- Increased working capital by $9.7 million from December 31, 2014 -
- To hold fourth quarter 2015 results conference call on Thursday, March 31st at 4:30 PM ET -

BEVERLY HILLS, Calif., March 31, 2016 (GLOBE NEWSWIRE) -- TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) (TOMI), a global bacteria decontamination and infection prevention company, announced its financial results for the fourth quarter and full year of 2015.

Dr. Halden Shane, TOMI’s Chief Executive Officer, stated: “Our efforts in 2015 led to several significant accomplishments and demonstrate the TOMI SteraMist platform is beginning to take hold around the world. Key regulatory agencies validated the effectiveness and competitive advantages of our technology and products. We also extended our penetration of the US and international markets by establishing strong manufacturing relationships and distribution channels. In addition, we fortified our operating and corporate infrastructure to support our rapid growth. Overall, our 2015 financial results improved significantly over 2014 and foreshadow our projected large-scale growth.

“In 2016, we have continued building our momentum. In fact, in February the Environmental Protection Agency (EPA) amended our registration for our patented Binary Ionization Technology (BIT) platform to include its effectiveness in disinfecting C. diff spores, MRSA and H1N1. This amendment significantly expands our market opportunity in the US hospital and healthcare channels, particularly as registration with state regulatory agencies progresses. To support our continued growth overseas, we signed a distribution agreement to establish TOMI Asia, which will serve multiple markets in the region by providing distribution, warehousing, sales, training, services and support for our suite of products.  

“We are excited about the opportunities before us. Committed to profitable growth, we are focused on the following initiatives:

  • Increasing penetration of the US Hospital-Healthcare Disinfectant market, including hospitals, surgical centers, medical, dental and veterinary offices;
  • Developing products that leverage our core competencies in decontamination and disinfection of indoor air and surfaces;
  • Maintaining a prudent cost structure while positioning the company for growth;
  • Enhancing  the breadth and depth of the TOMI Service Network; and,
  • Furthering our regulatory claims to unlock even more opportunities for market growth.”

Financial Results for the Three Months Ended December 31, 2015 Compared to 2014

  • Net revenue was $1.8 million, a 69% increase from $1.0 million reflecting the company’s expansion into new markets and geographies.
  • Gross margins were 60.7%, compared to 58.4%.
  • Loss from operations was $157,000, compared to $102,000.
  • Net loss was $157,000, or breakeven on a per share basis. In the fourth quarter of 2014 net income included a $2.0 million fair value adjustment on a derivative liability and was $1.2 million, $0.01 per diluted share.
  • At December 31, 2015, cash and cash equivalents were $5.9 million and working capital was
    $7.9 million, an increase of $9.7 million over the $1.8 million working capital deficit reported at December 31, 2014.

Financial Results for the Twelve Months Ended December 31, 2015 Compared to 2014

  • Net revenue was $4.2 million, an 86% increase from $2.2 million.
  • Gross margins were 60.8%, compared to 61.1%.
  • Loss from operations was $3.0 million, including $1.7 million in equity compensation expense. This compares to a loss from operations of $3.8 million in 2014, which included $2.6 million in equity compensation expense
  • Net loss was $12.2 million, or $0.12 per diluted share, compared to net income of $268,000, or breakeven on a per share basis. The increase in net loss was primarily attributed to one-time non-cash charges related to the liquidation of our outstanding convertible promissory notes.

Recent Business Highlights

  • Received an order valued at over $620,000 for the use of SteraMist products in healthcare facilities throughout Mexico.
  • Expanded the TOMI Service Network (TSN™) to 24 members as of December 31, 2015.
  • Signed a distribution agreement establishing TOMI Asia to serve multiple markets in the region by providing distribution, warehousing, sales, training, services and support for TOMI’s products.
  • Received a $500,000 order for TOMI’s SteraMist Surface Unit from Espire Health for deployment in new healthcare facilities in the Philippines.
  • Received a $400,000 order from SG Environmental Solutions, one of TOMI’s international distribution partners in Malaysia.
  • Made strategic hires including Robert Wotczak as President and Kenneth Kelliher as Vice President of Sales.
  • Added three experienced independent directors to TOMI’s board: Walter Johnsen; Kelly Anderson; and Edward Fred.

Conference Call Information
To listen to the call, please dial 1-888-339-0752 or 1-412-902-4193, passcode #10082191. To listen to the webcast or view the press release, please visit the Investor Relations section of the TOMI website at: http://www.tomiesinc.com/us/investors/. The replay can be accessed for up to 24 hours starting at 8:00 p.m. ET the day of the call by dialing 1-877-344-7529 or 1-412-317-0088, passcode #10082191. A replay of the webcast will be available for at least 90 days on the company’s website, starting approximately one hour after the completion of the call.

About TOMI™ Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. (OTCQB:TOMZ) is a global bacteria decontamination and infectious disease control company, providing eco-friendly environmental solutions for indoor surface decontamination through manufacturing, sales and licensing of our premier platform of Hydrogen Peroxide based products that uses Binary Ionization Technology® (BIT) , a state of the art technology for the production of its six-log mist represented by the TOMI™ SteraMist™ brand.

TOMI’s products are designed to service a broad spectrum of commercial structures including hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, for non-food safety in meat and produce processing facilities, military barracks, and athletic facilities. TOMI’s products and services have also been used in single-family homes and multi-unit residences.

TOMI also develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, The Restoration Industry Association, Indoor Air Quality Association, and The International Ozone Association. For additional product information, visit www.tomimist.com or contact us at info@tomimist.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

     
INVESTOR RELATIONS CONTACT:    MEDIA RELATIONS CONTACT:
Becky Herrick & Kirsten Chapman   Aaron Loveland
LHA (IR Agency)   VP of Marketing and Public Affairs 
(415) 433-3777   (240) 672-6263
tomi@lhai.com    aaron.loveland@tomiesinc.com  
     

 

[Tables to follow]

 
TOMI ENVIRONMENTAL SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
               
  For The Three Months Ended   For The Year Ended
  December 31,   December 31,
    2015       2014       2015       2014  
               
  Sales, net $   1,758,333     $   1,043,392     $   4,191,783     $   2,248,341  
  Cost of Sales     690,306         434,062         1,644,039         873,990  
  Gross profit     1,068,027         609,330         2,547,744         1,374,351  
               
Operating Expenses:              
  Professional Fees      124,999         69,380         455,626         349,546  
  Depreciation and Amortization      128,277         124,536         499,344         470,327  
  Selling Expenses      370,269         95,688         704,069         380,303  
  Research and Development      25,632         28,297         100,321         155,984  
  Consulting fees     19,901         51,318         476,513         179,809  
  Equity Compensation Expense (Note 8)     86,503         116,116         1,706,393         2,564,707  
  General and Administrative     469,073         226,314         1,591,102         1,083,885  
Total Operating Expenses     1,224,654         711,649         5,533,368         5,184,561  
Loss from Operations     (156,628 )       (102,319 )       (2,985,624 )       (3,810,210 )
               
Other Income (Expense):              
  Amortization of Deferred Financing Costs     -         (86,327 )       (199,625 )       (342,492 )
  Amortization of Debt Discounts     -         (517,742 )       (3,996,033 )       (1,007,525 )
  Fair Value Adjustment of Derivative Liability     -         2,036,658         (3,810,955 )       5,936,619  
  Induced Conversion Loss     -         -         (930,383 )       -  
  Interest Expense     -         (126,850 )       (253,700 )       (507,956 )
Total Other Income (Expense)     -         1,305,739         (9,190,695 )     4,078,646  
               
Net Income (Loss) $   (156,628 )   $   1,203,420     $   (12,176,319 )   $   268,436  
               
Income (Loss) Per Common Share              
Basic $   -     $   0.01     $   (0.12 )   $  -  
Diluted $ -     $   0.01     $   (0.12 )   $   -  
               
Basic Weighted Average Common Shares Outstanding      120,045,746         83,288,371         102,840,185         81,281,030  
Diluted Weighted Average Common Shares Outstanding      120,045,746         129,406,301         102,840,185         127,398,990  
               


TOMI ENVIRONMENTAL SOLUTIONS, INC.
CONSOLIDATED BALANCE SHEET
 
ASSETS      
Current Assets:      
  December 31, 2015   December 31, 2014
Cash and Cash Equivalents $ 5,916,068     $ 160,560  
Cash – Restricted (Note 6)     -        105,776  
Accounts Receivable – net   1,414,576       441,153  
Inventories (Note 3)   1,395,175       772,833  
Deposits on Merchandise (Note 11)   442,358         -  
Prepaid Expenses   76,730       35,404  
Other Assets   36,613       36,644  
Deferred Financing Costs – net (Note 6)     -       199,625  
Total Current Assets   9,281,519       1,751,995  
       
Property and Equipment – net (Note 4)   250,264       288,159  
       
Other Assets:      
Intangible Assets – net (Note 5)   2,287,548       2,657,056  
Security Deposits   4,700       6,552  
Total Other Assets   2,292,248       2,663,608  
Total Assets $ 11,824,031     $ 4,703,762  
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Current Liabilities:      
  Accounts Payable and Accrued Expenses $ 1,087,978     $ 448,063  
  Accrued Interest on Convertible Notes (Note 6)     -       211,417  
  Accrued Officers Compensation (Note 9)     -       41,000  
  Common Stock to be Issued (Note 13)   52,721       35,925  
  Customer Deposits   35,111       19,716  
  Deferred Rent   14,745       15,236  
  Advances on Grant (Note 11)   210,503         -  
  Derivative Liability (Note 7)     -       1,728,883  
  Convertible Notes Payable, net of discount at December 31, 2014 of $3,996,033 (Note 6)     -       1,077,967  
Total Current Liabilities   1,401,057       3,578,207  
       
Total Liabilities   1,401,057       3,578,207  
               
Commitments and Contingencies              
Stockholders’ Equity:              
Cumulative Convertible Series A Preferred Stock;              
 par value $0.01, 1,000,000 shares authorized; 510,000 shares issued              
 and outstanding at December 31, 2015 and December 31, 2014   5,100       5,100  
Cumulative Convertible Series B Preferred Stock; $1,000 stated value;              
 7.5% Cumulative dividend; 4,000 shares authorized; none issued              
 and outstanding at December 31, 2015 and December 31, 2014   -       -  
Common stock; par value $0.01, 200,000,000 shares authorized;              
 120,063,180 and 83,646,275 shares issued and outstanding              
 at December 31, 2015 and December 31, 2014, respectively.   1,200,632       836,463  
Additional Paid-In Capital   40,391,216       19,281,647  
Accumulated Deficit   (31,173,973 )     (18,997,655 )
Total Stockholders’ Equity   10,422,974       1,125,555  
Total Liabilities and Stockholders’ Equity $ 11,824,031     $ 4,703,762  

 

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.